DCF Tool


Kimberly-Clark Corp. – Sanitary Paper Product Manufacturing
kimberly-clark makes the essentials for a better life with well-known brands that matter every day – at home, school, work and on the go. throughout our 144 years, we have challenged conventional wisdom to innovate products that better meet the needs of consumers. we have created new categories with top brands like kleenex®, and redefined categories with huggies® and u by kotex®. while growing our $18+ billion global business, we help build careers through collaborative teams that push boundaries and engaging experiences and endless opportunities to work with some of the world’s most recognized brands. our 43,000 employees are changing the world for the better, too, generously giving back to communities and causes around the globe. if innovative thinking and a passion to win inspire you, come unleash your power at kimberly-clark.
Analysis Results
Intrinsic Value $134.46
Latest Price $123.48
Relative Value 8% undervalued
Thoughts on this result? Let us know.
Cash Flow (Billions)
Analysis Parameters
New Ticker
Analysis Details
Growth Rate Projection

An exponential growth model was fit to the past cash flow data, giving more weight to more recent years. This model determined a growth rate estimate of 0.8%.

Weighted Average Cost of Capital (WACC)

The calculated WACC is 5.9%. This value is used as the default discount rate.

Value of Future Flows

Assuming a growth rate of 0.8%, the cash flows for the next 5 years are projected.

The present value of each year's flow is adjusted to present value using the discount rate.

Year Future flow (billion) Present value (billion)
2023 1.96 1.85
2024 1.98 1.76
2025 2.0 1.68
2026 2.01 1.6
2027 2.03 1.52
Terminal Value

Assuming a growth rate after the projection years of 2.0%, the terminal value of the company would be 52.4 billion. This corresponds to a present value of 37.1 billion.

Intrinsic Value Per Share

The total present value of the projected cash flows is 8.41 billion. Adding in the terminal value gives a total present value of 45.5 billion.

There are presently 338.0 million outstanding shares, so the intrinsic value per share is 134.46.

Financial Statements

The following data was to determine the past cash flows.

Current Assets 5,729,000,000
Current Cash 427,000,000
Current Liabilities 7,334,000,000
Current Debt 844,000,000
Non-Cash Working Capital (NCWC) -1,188,000,000
Change in NCWC -167,000,000
EBIT 2,754,000,000
Tax Provision 495,000,000
Depreciation and Amortization 754,000,000
Capital Expenditure -876,000,000
Unlevered Free Cash Flow 1,909,938,925
Current Assets 5,565,000,000
Current Cash 270,000,000
Current Liabilities 6,749,000,000
Current Debt 433,000,000
Non-Cash Working Capital (NCWC) -1,021,000,000
Change in NCWC 65,000,000
EBIT 2,687,000,000
Tax Provision 479,000,000
Depreciation and Amortization 766,000,000
Capital Expenditure -1,007,000,000
Unlevered Free Cash Flow 1,956,943,607
Current Assets 5,174,000,000
Current Cash 303,000,000
Current Liabilities 6,443,000,000
Current Debt 486,000,000
Non-Cash Working Capital (NCWC) -1,086,000,000
Change in NCWC -316,000,000
EBIT 3,332,000,000
Tax Provision 676,000,000
Depreciation and Amortization 796,000,000
Capital Expenditure -1,217,000,000
Unlevered Free Cash Flow 1,861,786,458
Current Assets 5,057,000,000
Current Cash 442,000,000
Current Liabilities 6,919,000,000
Current Debt 1,534,000,000
Non-Cash Working Capital (NCWC) -770,000,000
Change in NCWC 56,000,000
EBIT 2,904,000,000
Tax Provision 576,000,000
Depreciation and Amortization 917,000,000
Capital Expenditure -1,209,000,000
Unlevered Free Cash Flow 2,064,789,037
Current Assets 5,041,000,000
Current Cash 539,000,000
Current Liabilities 6,536,000,000
Current Debt 1,208,000,000
Non-Cash Working Capital (NCWC) -826,000,000
Change in NCWC -516,000,000
EBIT 2,333,000,000
Tax Provision 471,000,000
Depreciation and Amortization 882,000,000
Capital Expenditure -877,000,000
Unlevered Free Cash Flow 1,248,491,127
Current Assets 5,211,000,000
Current Cash 616,000,000
Current Liabilities 5,858,000,000
Current Debt 953,000,000
Non-Cash Working Capital (NCWC) -310,000,000
Change in NCWC 211,000,000
EBIT 3,430,000,000
Tax Provision 776,000,000
Depreciation and Amortization 724,000,000
Capital Expenditure -785,000,000
Unlevered Free Cash Flow 2,720,006,462
Current Assets 5,115,000,000
Current Cash 923,000,000
Current Liabilities 5,846,000,000
Current Debt 1,133,000,000
Non-Cash Working Capital (NCWC) -521,000,000
Change in NCWC -648,000,000
EBIT 3,457,000,000
Tax Provision 922,000,000
Depreciation and Amortization 705,000,000
Capital Expenditure -771,000,000
Unlevered Free Cash Flow 1,728,242,279
Current Assets 5,426,000,000
Current Cash 619,000,000
Current Liabilities 6,349,000,000
Current Debt 1,669,000,000
Non-Cash Working Capital (NCWC) 127,000,000
Change in NCWC 257,000,000
EBIT 3,330,000,000
Tax Provision 418,000,000
Depreciation and Amortization 746,000,000
Capital Expenditure -1,056,000,000
Unlevered Free Cash Flow 2,339,035,040
Current Assets 5,559,000,000
Current Cash 789,000,000
Current Liabilities 6,226,000,000
Current Debt 1,326,000,000
Non-Cash Working Capital (NCWC) -130,000,000
Change in NCWC -659,000,000
EBIT 3,120,000,000
Tax Provision 856,000,000
Depreciation and Amortization 862,000,000
Capital Expenditure -1,039,000,000
Unlevered Free Cash Flow 1,171,663,473
Current Assets 6,550,000,000
Current Cash 1,054,000,000
Current Liabilities 5,848,000,000
Current Debt 881,000,000
Non-Cash Working Capital (NCWC) 529,000,000
Change in NCWC 22,000,000
EBIT 3,417,000,000
Tax Provision 929,000,000
Depreciation and Amortization 863,000,000
Capital Expenditure -953,000,000
Unlevered Free Cash Flow 2,341,256,190
Current Assets 6,589,000,000
Current Cash 1,106,000,000
Current Liabilities 6,091,000,000
Current Debt 1,115,000,000
Non-Cash Working Capital (NCWC) 507,000,000
Change in NCWC -321,000,000
EBIT 2,856,000,000
Tax Provision 768,000,000
Depreciation and Amortization 857,000,000
Capital Expenditure -1,093,000,000
Unlevered Free Cash Flow 1,454,081,664

This analysis is provided for informational purposes only and does not constitute financial or investing advice. For more information on the advantages and limitations of DCF analysis see background. This information is provided on an "as is" basis. No warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. By using this site you agree that under no circumstances shall Valuation Tools LLC be held liable for any loss or damage caused by information obtained from this website including any articles, data, videos, its social media accounts, or any other materials.